DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody

Abstract

The MERS-CoV is an emerging virus, which already infected more than 1,300 humans with high (~36%) mortality. Here, we show that m336, an exceptionally potent human anti-MERS-CoV antibody, is almost germline with only one somatic mutation in the heavy chain. The structure of Fab m336 in complex with the MERS-CoV receptor-binding domain reveals that its IGHV1-69-derived heavy chain provides more than 85% binding surface and that its epitope almost completely overlaps with the receptor-binding site. Analysis of antibodies from 69 healthy humans suggests an important role of the V(D)J recombination-generated junctional and allele-specific residues for achieving high affinity of binding at such low levels of somatic hypermutation. Our results also have important implications for development of vaccine immunogens based on the newly identified m336 epitope as well as for elucidation of mechanisms of neutralization by m336-like antibodies and their elicitation in vivo.

Authors:
 [1];  [2];  [3];  [4];  [2];  [2];  [4];  [5];  [6];  [2];  [4]
  1. Fudan Univ., Shanghai (China). Shanghai Medical College
  2. National Inst. of Health (NIH), Frederick, MD (United States). National Cancer Inst.
  3. New York Blood Center, New York, NY (United States). Lindsley F. Kimball Research Inst.
  4. National Inst. of Health (NIH), Bethesda, MD (United States). National Inst. of Allergy and Infectious Diseases
  5. Fudan Univ., Shanghai (China). Shanghai Medical College; National Inst. of Health (NIH), Frederick, MD (United States). National Cancer Inst.
  6. Fudan Univ., Shanghai (China). Shanghai Medical College; New York Blood Center, New York, NY (United States). Lindsley F. Kimball Research Inst.
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
OSTI Identifier:
1214653
Grant/Contract Number:  
W-31-109-ENG-38
Resource Type:
Accepted Manuscript
Journal Name:
Nature Communications
Additional Journal Information:
Journal Volume: 6; Journal ID: ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 60 APPLIED LIFE SCIENCES

Citation Formats

Ying, Tianlei, Prabakaran, Ponraj, Du, Lanying, Shi, Wei, Feng, Yang, Wang, Yanping, Wang, Lingshu, Li, Wei, Jiang, Shibo, Dimitrov, Dimiter S., and Zhou, Tongqing. Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody. United States: N. p., 2015. Web. doi:10.1038/ncomms9223.
Ying, Tianlei, Prabakaran, Ponraj, Du, Lanying, Shi, Wei, Feng, Yang, Wang, Yanping, Wang, Lingshu, Li, Wei, Jiang, Shibo, Dimitrov, Dimiter S., & Zhou, Tongqing. Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody. United States. https://doi.org/10.1038/ncomms9223
Ying, Tianlei, Prabakaran, Ponraj, Du, Lanying, Shi, Wei, Feng, Yang, Wang, Yanping, Wang, Lingshu, Li, Wei, Jiang, Shibo, Dimitrov, Dimiter S., and Zhou, Tongqing. Tue . "Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody". United States. https://doi.org/10.1038/ncomms9223. https://www.osti.gov/servlets/purl/1214653.
@article{osti_1214653,
title = {Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody},
author = {Ying, Tianlei and Prabakaran, Ponraj and Du, Lanying and Shi, Wei and Feng, Yang and Wang, Yanping and Wang, Lingshu and Li, Wei and Jiang, Shibo and Dimitrov, Dimiter S. and Zhou, Tongqing},
abstractNote = {The MERS-CoV is an emerging virus, which already infected more than 1,300 humans with high (~36%) mortality. Here, we show that m336, an exceptionally potent human anti-MERS-CoV antibody, is almost germline with only one somatic mutation in the heavy chain. The structure of Fab m336 in complex with the MERS-CoV receptor-binding domain reveals that its IGHV1-69-derived heavy chain provides more than 85% binding surface and that its epitope almost completely overlaps with the receptor-binding site. Analysis of antibodies from 69 healthy humans suggests an important role of the V(D)J recombination-generated junctional and allele-specific residues for achieving high affinity of binding at such low levels of somatic hypermutation. Our results also have important implications for development of vaccine immunogens based on the newly identified m336 epitope as well as for elucidation of mechanisms of neutralization by m336-like antibodies and their elicitation in vivo.},
doi = {10.1038/ncomms9223},
journal = {Nature Communications},
number = ,
volume = 6,
place = {United States},
year = {Tue Sep 15 00:00:00 EDT 2015},
month = {Tue Sep 15 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 90 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
journal, July 2012


Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
journal, July 2010


Rapid development of broadly influenza neutralizing antibodies through redundant mutations
journal, October 2014

  • Pappas, Leontios; Foglierini, Mathilde; Piccoli, Luca
  • Nature, Vol. 516, Issue 7531
  • DOI: 10.1038/nature13764

Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
journal, January 2013


Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
journal, March 2013


Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
journal, July 2007

  • Zhu, Z.; Chakraborti, S.; He, Y.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 29
  • DOI: 10.1073/pnas.0701000104

Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody
journal, June 2014


Therapeutic antibodies, vaccines and antibodyomes
journal, May 2010


B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
journal, May 2012

  • Haynes, Barton F.; Kelsoe, Garnett; Harrison, Stephen C.
  • Nature Biotechnology, Vol. 30, Issue 5
  • DOI: 10.1038/nbt.2197

Structural and genetic basis for development of broadly neutralizing influenza antibodies
journal, August 2012

  • Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.
  • Nature, Vol. 489, Issue 7417
  • DOI: 10.1038/nature11371

Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies
journal, December 2014


Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
journal, November 2012

  • Zaki, Ali M.; van Boheemen, Sander; Bestebroer, Theo M.
  • New England Journal of Medicine, Vol. 367, Issue 19
  • DOI: 10.1056/NEJMoa1211721

Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
journal, November 2012

  • van Boheemen, Sander; de Graaf, Miranda; Lauber, Chris
  • mBio, Vol. 3, Issue 6
  • DOI: 10.1128/mBio.00473-12

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
journal, August 2014

  • Yang, Y.; Du, L.; Liu, C.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 34
  • DOI: 10.1073/pnas.1405889111

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
journal, March 2013

  • Raj, V. Stalin; Mou, Huihui; Smits, Saskia L.
  • Nature, Vol. 495, Issue 7440
  • DOI: 10.1038/nature12005

A decade after SARS: strategies for controlling emerging coronaviruses
journal, November 2013

  • Graham, Rachel L.; Donaldson, Eric F.; Baric, Ralph S.
  • Nature Reviews Microbiology, Vol. 11, Issue 12
  • DOI: 10.1038/nrmicro3143

Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
journal, April 2014


Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
journal, April 2014

  • Tang, X. -C.; Agnihothram, S. S.; Jiao, Y.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 19
  • DOI: 10.1073/pnas.1402074111

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
journal, February 2015


Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
journal, November 2013


Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
journal, July 2013

  • Wang, Nianshuang; Shi, Xuanling; Jiang, Liwei
  • Cell Research, Vol. 23, Issue 8
  • DOI: 10.1038/cr.2013.92

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis
journal, May 2008

  • Brochet, X.; Lefranc, M. -P.; Giudicelli, V.
  • Nucleic Acids Research, Vol. 36, Issue Web Server
  • DOI: 10.1093/nar/gkn316

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
journal, February 2004

  • Huang, C. -c.; Venturi, M.; Majeed, S.
  • Proceedings of the National Academy of Sciences, Vol. 101, Issue 9
  • DOI: 10.1073/pnas.0308527100

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
journal, February 2009

  • Sui, Jianhua; Hwang, William C.; Perez, Sandra
  • Nature Structural & Molecular Biology, Vol. 16, Issue 3
  • DOI: 10.1038/nsmb.1566

Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing
journal, January 2012


The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries
journal, July 2005

  • Kramer, R. Arjen; Marissen, Wilfred E.; Goudsmit, Jaap
  • European Journal of Immunology, Vol. 35, Issue 7
  • DOI: 10.1002/eji.200526134

Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation
journal, April 2014


Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
journal, August 2011


Evaluation of candidate vaccine approaches for MERS-CoV
journal, July 2015

  • Wang, Lingshu; Shi, Wei; Joyce, M. Gordon
  • Nature Communications, Vol. 6, Issue 1
  • DOI: 10.1038/ncomms8712

[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

The CCP4 suite programs for protein crystallography
journal, September 1994


PHENIX : building new software for automated crystallographic structure determination
journal, October 2002

  • Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei
  • Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11
  • DOI: 10.1107/S0907444902016657

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
journal, May 2007

  • Davis, I. W.; Leaver-Fay, A.; Chen, V. B.
  • Nucleic Acids Research, Vol. 35, Issue Web Server
  • DOI: 10.1093/nar/gkm216

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
journal, April 2006

  • Prabakaran, Ponraj; Gan, Jianhua; Feng, Yang
  • Journal of Biological Chemistry, Vol. 281, Issue 23
  • DOI: 10.1074/jbc.M600697200

Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
journal, February 2010

  • Chen, Weizao; Zhu, Zhongyu; Liao, Huaxin
  • Viruses, Vol. 2, Issue 2
  • DOI: 10.3390/v2020547

IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling
journal, September 2013

  • Li, Shuo; Lefranc, Marie-Paule; Miles, John J.
  • Nature Communications, Vol. 4, Issue 1
  • DOI: 10.1038/ncomms3333

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
text, January 2014

  • A., Marasco, Wayne; Jared, Sheehan,; L., Graham, Rachel
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/7xm3-1892

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
text, January 2014

  • Liu, Chang; Wang, Lili; Li, Fang
  • National Academy of Sciences of the United States of America
  • DOI: 10.17615/g09d-nd11

A decade after SARS: strategies for controlling emerging coronaviruses
text, January 2013

  • Graham, Rachel L.; Donaldson, Eric F.; Baric, Ralph S.
  • Macmillan Publishers
  • DOI: 10.17615/ss8c-tg10

Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
text, January 2013

  • Hoot, Sam; McGuire, Andrew T.; Cohen, Kristen W.
  • Public Library of Science (PLoS)
  • DOI: 10.5167/uzh-110380

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
text, January 2007

  • B., Chen, Vincent; C., Richardson, David; S., Richardson, Jane
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/m2an-p252

The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries
journal, July 2005

  • Kramer, R. Arjen; Marissen, Wilfred E.; Goudsmit, Jaap
  • European Journal of Immunology, Vol. 35, Issue 7
  • DOI: 10.1002/eji.200526134

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
journal, February 2015


Junctional Amino Acids Determine the Maturation Pathway of an Antibody
journal, September 1999


Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
journal, October 2013

  • Reusken, Chantal BEM; Haagmans, Bart L.; Müller, Marcel A.
  • The Lancet Infectious Diseases, Vol. 13, Issue 10
  • DOI: 10.1016/s1473-3099(13)70164-6

Spiking the MERS-coronavirus receptor
journal, August 2013

  • Bosch, Berend Jan; Raj, V. Stalin; Haagmans, Bart L.
  • Cell Research, Vol. 23, Issue 9
  • DOI: 10.1038/cr.2013.108

Structural and genetic basis for development of broadly neutralizing influenza antibodies
journal, August 2012

  • Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.
  • Nature, Vol. 489, Issue 7417
  • DOI: 10.1038/nature11371

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
journal, March 2013

  • Raj, V. Stalin; Mou, Huihui; Smits, Saskia L.
  • Nature, Vol. 495, Issue 7440
  • DOI: 10.1038/nature12005

B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
journal, May 2012

  • Haynes, Barton F.; Kelsoe, Garnett; Harrison, Stephen C.
  • Nature Biotechnology, Vol. 30, Issue 5
  • DOI: 10.1038/nbt.2197

A decade after SARS: strategies for controlling emerging coronaviruses
journal, November 2013

  • Graham, Rachel L.; Donaldson, Eric F.; Baric, Ralph S.
  • Nature Reviews Microbiology, Vol. 11, Issue 12
  • DOI: 10.1038/nrmicro3143

Emerging Human Coronaviruses — Disease Potential and Preparedness
journal, November 2012

  • Anderson, Larry J.; Baric, Ralph S.
  • New England Journal of Medicine, Vol. 367, Issue 19
  • DOI: 10.1056/nejme1212300

Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus
journal, August 2013

  • Assiri, Abdullah; McGeer, Allison; Perl, Trish M.
  • New England Journal of Medicine, Vol. 369, Issue 5
  • DOI: 10.1056/nejmoa1306742

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
journal, February 2004

  • Huang, C. -c.; Venturi, M.; Majeed, S.
  • Proceedings of the National Academy of Sciences, Vol. 101, Issue 9
  • DOI: 10.1073/pnas.0308527100

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
journal, July 2007

  • Zhu, Z.; Chakraborti, S.; He, Y.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 29
  • DOI: 10.1073/pnas.0701000104

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
journal, August 2014

  • Yang, Y.; Du, L.; Liu, C.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 34
  • DOI: 10.1073/pnas.1405889111

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/s0907444904019158

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
journal, July 2010


Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
journal, July 2012


Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
journal, March 2013


Expanding the breadth of an HIV-1 vaccine
journal, December 2014


Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection
journal, February 2014

  • Barlan, A.; Zhao, J.; Sarkar, M. K.
  • Journal of Virology, Vol. 88, Issue 9
  • DOI: 10.1128/jvi.00161-14

Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
journal, April 2014

  • Ying, Tianlei; Du, Lanying; Ju, Tina W.
  • Journal of Virology, Vol. 88, Issue 14
  • DOI: 10.1128/jvi.00912-14

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
text, January 2014

  • A., Marasco, Wayne; Jared, Sheehan,; L., Graham, Rachel
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/7xm3-1892

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
text, January 2007

  • B., Chen, Vincent; C., Richardson, David; S., Richardson, Jane
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/m2an-p252

Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation
journal, April 2014


Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing
journal, January 2012


Works referencing / citing this record:

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
journal, November 2016

  • Du, Lanying; Tai, Wanbo; Yang, Yang
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms13473

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
journal, April 2017

  • Yuan, Yuan; Cao, Duanfang; Zhang, Yanfang
  • Nature Communications, Vol. 8, Issue 1
  • DOI: 10.1038/ncomms15092

Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
journal, September 2016

  • Walls, Alexandra C.; Tortorici, M. Alejandra; Frenz, Brandon
  • Nature Structural & Molecular Biology, Vol. 23, Issue 10
  • DOI: 10.1038/nsmb.3293

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
journal, July 2019


A novel non-enzymatic hydrolytic probe for dipeptidyl peptidase IV specific recognition and imaging
journal, January 2018

  • Xing, Jie; Gong, Qiuyu; Zhang, Renshuai
  • Chemical Communications, Vol. 54, Issue 63
  • DOI: 10.1039/c8cc05048a

Structure–function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity
journal, March 2018

  • Shiroishi, Mitsunori; Ito, Yuji; Shimokawa, Kenta
  • Journal of Biological Chemistry, Vol. 293, Issue 18
  • DOI: 10.1074/jbc.m117.814475

MERS-CoV spike protein: a key target for antivirals
journal, December 2016


Antibodies and vaccines against Middle East respiratory syndrome coronavirus
journal, January 2019


A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
journal, June 2019


High-Throughput Sequencing-Based Immune Repertoire Study during Infectious Disease
journal, August 2016


Insights into the Structural Basis of Antibody Affinity Maturation from Next-Generation Sequencing
journal, February 2018


Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
journal, November 2019


A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
journal, August 2018


Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
journal, January 2019

  • Zhou, Yusen; Yang, Yang; Huang, Jingwei
  • Viruses, Vol. 11, Issue 1
  • DOI: 10.3390/v11010060

Development of a Phage Display Panning Strategy Utilizing Crude Antigens: Isolation of MERS-CoV Nucleoprotein human antibodies
journal, April 2019


Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
journal, January 2020


Molecular aspects of MERS-CoV
journal, May 2017


The prevalence, origin, and prevention of six human coronaviruses
journal, February 2016


MERS-CoV spike protein: Targets for vaccines and therapeutics
journal, September 2016


Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets
journal, July 2017


Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
journal, July 2018


A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin
journal, October 2017


The Individual and Population Genetics of Antibody Immunity
journal, July 2017

  • Watson, Corey T.; Glanville, Jacob; Marasco, Wayne A.
  • Trends in Immunology, Vol. 38, Issue 7
  • DOI: 10.1016/j.it.2017.04.003

Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
journal, January 2018

  • Mustafa, Sabeena; Balkhy, Hanan; Gabere, Musa N.
  • Journal of Infection and Public Health, Vol. 11, Issue 1
  • DOI: 10.1016/j.jiph.2017.08.009

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
journal, March 2018


Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
journal, January 2017

  • Wu, Yanling; Li, Shun; Du, Lanying
  • Emerging Microbes & Infections, Vol. 6, Issue 1
  • DOI: 10.1038/emi.2017.79

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
journal, November 2016

  • Du, Lanying; Tai, Wanbo; Yang, Yang
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms13473

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
journal, April 2017

  • Yuan, Yuan; Cao, Duanfang; Zhang, Yanfang
  • Nature Communications, Vol. 8, Issue 1
  • DOI: 10.1038/ncomms15092

Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
journal, September 2016

  • Walls, Alexandra C.; Tortorici, M. Alejandra; Frenz, Brandon
  • Nature Structural & Molecular Biology, Vol. 23, Issue 10
  • DOI: 10.1038/nsmb.3293

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
journal, July 2019


Development of a Phage Display Panning Strategy Utilizing Crude Antigens: Isolation of MERS-CoV Nucleoprotein human antibodies
journal, April 2019


Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
journal, December 2016


Antibodies and vaccines against Middle East respiratory syndrome coronavirus
journal, January 2019


Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient
journal, May 2018

  • Niu, Peihua; Zhang, Senyan; Zhou, Panpan
  • The Journal of Infectious Diseases, Vol. 218, Issue 8
  • DOI: 10.1093/infdis/jiy311

Characterization and bioactivity of self-assembled anti-angiogenic chondroitin sulphate-ES2-AF nanoparticle conjugate


journal, April 2019

  • Xing, Liang; Sun, Feng; Wang, Zhendong
  • International Journal of Nanomedicine, Vol. Volume 14
  • DOI: 10.2147/ijn.s195934

Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
journal, November 2019


A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
journal, August 2018


Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
journal, January 2019

  • Zhou, Yusen; Yang, Yang; Huang, Jingwei
  • Viruses, Vol. 11, Issue 1
  • DOI: 10.3390/v11010060